This article, written with co-authors Bruce H. Kobayashi, Joshua D. Wright, and Douglas H. Ginsburg, examines the economics of litigation and settlement of patent disputes arising from Paragraph IV Abbreviated New Drug Application (ANDA) filings under the Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act) within the framework set out in Actavis.
Dr. Alison Hole joins CRA's Antitrust & Competition Economics Practice
CRA is pleased to announce that Dr. Alison Hole has joined the company as a Vice President in the Antitrust & Competition Economics Practice.